An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.
about
PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilastEffects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn ratsPhosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.Inhibition of cyclooxygenase-2 prevents adverse effects induced by phosphodiesterase type 4 inhibitors in ratsUpdate on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease.Treating COPD with PDE 4 inhibitors.Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring.Salmeterol/fluticasone propionate combination in the treatment of COPD.Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD.Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseEfficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes.Roflumilast: a green signal is yet to comeA multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice.Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.Clarithromycin prevents smoke-induced emphysema in mice.Meeting highlights of the European Respiratory Society annual congress 02-06 September 2006, Munich, Germany.Synthesis of PDE IV inhibitors. First asymmetric synthesis of two of GlaxoSmithKline's highly potent Rolipram analogues.Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge.Advances in the synthesis of 7-(3-cyclopentyloxy-4-methoxyphenyl)-hexahydro-3H-pyrrolizin-3-one (Pyrromilast)–a promising agent for treatment of chronic obstructive pulmonary diseaseSynthesis of phosphodiesterase IVb inhibitors 2. Stereoselective synthesis of hexahydro-3H-pyrrolo[1,2-c]imidazol-3-one and tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-one derivativesPharmacotherapy of Chronic Obstructive Pulmonary Disease: A Clinical Review
P2860
Q24646836-09442A22-614A-4ECF-B052-CCF928112BBDQ33378441-C66506AC-61DF-47C9-A60B-519FB9483633Q33624262-FDD9B0A6-4EE0-418A-AAA8-1A81EF2288FDQ34540209-CA54AA00-C242-42F5-AE72-C75F8EAE78F5Q35028812-808EF2E5-481F-4B9D-A863-0148214BCE8AQ37082594-91EE61ED-33C3-4ED3-A0C8-94E26C964762Q37554404-509384F8-10B3-4C63-91EB-036DD6B372F3Q37754942-576B2332-9A14-4D61-8920-D57668BF9B98Q37778289-1D7BCF32-2BE9-489C-BC26-1DB86B5A47F0Q37828179-3ADF64E2-0E22-4309-BD2B-7D5A7D5F304FQ38063794-06B592A1-5AA1-4BB3-B25F-733BE58DBB0BQ40159932-AC191CB5-3ACA-4975-8DB3-C31BF21962E2Q41375399-B24BF6FE-5587-4CAE-BB4F-786E1FC03FACQ41477802-350CFBD5-B5CA-4D77-9480-72E4C24CC3C6Q41980556-8EF019A8-579E-47D3-A0DD-EA24DCFED3ADQ43652179-F27CE8E8-19F6-4DF7-87A2-6F49D7DFC28CQ44603884-FEA498E4-A23F-4611-9290-D2DC1E698C8FQ44828383-336BFA67-225F-4DDF-91CF-03A90C46009CQ51758105-039F9FD0-16F9-41EE-8DE5-C6EC814A7AF3Q58365057-BFCBDF4D-BAB1-43C2-8CA0-FF6072927A3FQ58365163-61538A36-C17E-4FE5-9734-86CF627BCE32Q58997823-CFBD9DED-A015-466C-A6EB-B5A66D5567EF
P2860
An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
An update and appraisal of the ...... obstructive pulmonary disease.
@ast
An update and appraisal of the ...... obstructive pulmonary disease.
@en
type
label
An update and appraisal of the ...... obstructive pulmonary disease.
@ast
An update and appraisal of the ...... obstructive pulmonary disease.
@en
prefLabel
An update and appraisal of the ...... obstructive pulmonary disease.
@ast
An update and appraisal of the ...... obstructive pulmonary disease.
@en
P2860
P1476
An update and appraisal of the ...... obstructive pulmonary disease.
@en
P2093
Mark A Giembycz
P2860
P304
P356
10.1111/J.1365-2125.2006.02640.X
P407
P577
2006-08-01T00:00:00Z